ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665514 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665514; 2) Community: the network communities that were significantly associated with the response to NSC 665514; 3) Molecule: the relationships between components within communities and NSC 665514; 4) MDR: the compounds that were significantly associated with the NSC 665514.

NSC Compound Enrichment Correlation
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0385613993886001 0.20813966
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0385613993886001 0.23333145
NSC 733503 cis-6-(3-Bromopropyl)-12,13-dihydro-8,9-dimethoxy-3-nitro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0385613993886001 0.16568406
NSC 733504 Everolimus 0.0385613993886001 -0.2667243
NSC 735408 Null 0.0385613993886001 0.31365244
NSC 736802 Null 0.0385613993886001 0.32946456
NSC 746540 Null 0.0385613993886001 0.43583433
NSC 748715 Null 0.0385613993886001 0.25305089
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0385613993886001 0.5791891
NSC 753769 Null 0.0385613993886001 -0.16207064
Total:84  Current:67    [First] [Prev] [Next] [Last]